GlassScriptPhysician profile
William C Sternfeld
NPI 1366441651
$1,250.05
in general payments reported to CMS, 2019-2025
17 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $188 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $223.51 | 2019-2020 | |
| Stryker Corporation | $219.92 | 2025 | Spy-Phi System, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $209.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Z-Medica, LLC | $149.81 | 2019 | |
| Davol INC. | $147.48 | 2025 | Phasix Mesh |
| Atricure, INC. | $57.52 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Shire North American Group INC | $50.24 | 2019 | |
| Tela Bio, INC. | $27.17 | 2020 | |
| Polarityte, INC. | $26.19 | 2019 | |
| Abbvie INC. | $21.06 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.91 | 2019 | |
| Corcept Therapeutics | $18.53 | 2019 | |
| Celularity INC. | $18.00 | 2019 | |
| Covidien LP | $16.07 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $15.56 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.42 | 2019 | |
| Innovation Technologies INC | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sternfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.